norethindrone has been researched along with phenobarbital in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (72.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Bolt, HM; Kappus, H | 1 |
| Back, DJ; Breckenridge, AM; Gay, FE; Rowe, PH; Smith, E | 1 |
| Blakey, DC; White, IN | 1 |
| Böhm, W; Carol, W; Hempel, E; Klinger, G | 1 |
| Bellward, GD; Morgan, RG; Szombathy, VH | 1 |
| Hüthwohl, B; Kahl, GF; Kahl, R; Tüttenberg, KH | 1 |
| Cook, CE; Freudenthal, RI; Rosenfeld, R; Twine, M; Wall, ME | 1 |
| Cosmides, GJ | 1 |
| Conney, AH; Levin, W; Welch, RM | 1 |
| Back, DJ; Macnee, CM; Orme, ML; Rowe, PH; Smith, E | 1 |
| Back, DJ; Breckenridge, AM; Crawford, F; Cross, K; MacIver, M; Orme, ML; Rowe, PH; Smith, E | 1 |
| Back, DJ; Breckenridge, AM; Crawford, FE; Orme, ML; Rowe, PH | 1 |
| Back, DJ; Bates, M; Bowden, A; Breckenridge, AM; Hall, MJ; Jones, H; MacIver, M; Orme, M; Perucca, E; Richens, A; Rowe, PH; Smith, E | 1 |
1 review(s) available for norethindrone and phenobarbital
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
17 other study(ies) available for norethindrone and phenobarbital
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Irreversible protein binding of norethisterone (norethindrone) epoxide.
Topics: Animals; Cattle; Cytosol; Epoxy Compounds; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; NADP; Norethindrone; Phenobarbital; Protein Binding; Rats; Serum Albumin, Bovine; Xanthine Oxidase | 1976 |
The pharmacokinetics of norethisterone in the rabbit and rat after systemic and oral administration: effect of phenobarbitone [proceedings].
Topics: Administration, Oral; Animals; Drug Interactions; Female; Injections, Intravenous; Kinetics; Norethindrone; Phenobarbital; Rabbits; Rats | 1977 |
Destruction of cytochrome P-450 and formation of green pigments by contraceptive steroids in rat hepatocyte suspensions.
Topics: Animals; Cells, Cultured; Cytochrome P-450 Enzyme System; Humans; Liver; Male; Methylcholanthrene; Norethindrone; Phenobarbital; Pigments, Biological; Proadifen; Rats; Rats, Inbred F344; Steroids; Structure-Activity Relationship; Suspensions; Time Factors | 1986 |
[Enzyme induction by drugs and hormonal contraception].
Topics: Adult; Analgesics; Anti-Bacterial Agents; Anticonvulsants; Biopsy; Chlormadinone Acetate; Contraceptives, Oral; Drug Interactions; Endometrium; Enzyme Induction; Female; Humans; Mestranol; Norethindrone; Phenobarbital; Pregnancy; Sulfonamides; Tranquilizing Agents; Uterine Hemorrhage | 1973 |
The effects of pretreatment of mice with norethindrone on the metabolism of 14C-imipramine by the liver microsomal drug-metabolizing enzymes.
Topics: Animals; Carbon Radioisotopes; Chromatography, Thin Layer; Cobalt; Cytochrome c Group; Cytochrome Reductases; Dealkylation; Desipramine; Female; Hydrogen-Ion Concentration; Hydroxylation; Imipramine; Methylcholanthrene; Mice; Microsomes, Liver; NADP; Norethindrone; Oxides; Phenobarbital; Proadifen; Time Factors | 1974 |
Effects of synthetic progestagens on drug metabolism in rat liver microsomes.
Topics: Aerobiosis; Allyl Compounds; Aniline Compounds; Animals; Anisoles; Dealkylation; Estranes; Hydroxylation; Hydroxysteroids; In Vitro Techniques; Kinetics; Lynestrenol; Male; Microsomes, Liver; Nitro Compounds; Norethindrone; Norgestrel; Oxidation-Reduction; Pharmaceutical Preparations; Phenobarbital; Progestins; Rats; Spectrophotometry | 1974 |
Metabolism of norethynodrel by rat liver.
Topics: Alcohols; Animals; Biotransformation; Capillaries; Cattle; Chromatography, Gas; Chromatography, Thin Layer; Enzyme Induction; Escherichia coli; Glucuronidase; Hydroxylation; In Vitro Techniques; Ketosteroids; Liver; Male; Microsomes, Liver; Norethindrone; Norethynodrel; Oxidation-Reduction; Phenobarbital; Pregnanes; Rats; Snails; Subcellular Fractions; Sulfatases; Time Factors; Tritium | 1971 |
Pharmacology-toxicology.
Topics: Antidepressive Agents; Blood Pressure; Brain; Contraceptives, Oral; Cytochromes; Desipramine; Diazepam; Endoplasmic Reticulum; Histamine; Lidocaine; Liver; Methylphenidate; Methyltyrosines; National Institutes of Health (U.S.); Norepinephrine; Norethindrone; Nortriptyline; Oxyphenbutazone; Pharmaceutical Preparations; Phenobarbital; Placenta; Progesterone; Smoking; United States | 1970 |
Decreased uterotropic potency of oral contraceptives in rats pretreated with phenobarbital.
Topics: Animals; Carbon Isotopes; Contraceptives, Oral; Diethylstilbestrol; Ethinyl Estradiol; Female; Liver; Mestranol; Microsomes; Norethindrone; Norethynodrel; Organ Size; Phenobarbital; Rats; Tritium; Uterus | 1968 |
An investigation of the effects of phenobarbitone on the pharmacokinetics of norethindrone in the rat using liver perfusion and everted gut sacs.
Topics: Animals; Enzyme Induction; Female; Ileum; In Vitro Techniques; Kinetics; Liver; Norethindrone; Perfusion; Phenobarbital; Rats; Rats, Inbred Strains | 1984 |
Influence of environmental chemicals on drug therapy in humans: studies with contraceptive steroids.
Topics: Animals; Antipyrine; Contraceptives, Oral; Environment; Ethinyl Estradiol; Female; Half-Life; Humans; Intestinal Mucosa; Jejunum; Kinetics; Norethindrone; Norgestrel; Phenobarbital; Rats; Rifampin | 1980 |
Phenobarbitone interaction with oral contraceptive steroids in the rabbit and rat.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Digestive System; Drug Interactions; Enzyme Induction; Ethinyl Estradiol; Female; Kinetics; Norethindrone; Phenobarbital; Rabbits; Rats; Sleep; Time Factors | 1980 |
The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy.
Topics: Adolescent; Adult; Anticonvulsants; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Norethindrone; Norgestrel; Phenobarbital; Prospective Studies; Retrospective Studies | 1980 |